Intracranial Aneurysm Market - Top Companies and Manufacturers

Companies Dominating the Intracranial Aneurysm Market

Key players are investing in R&D to improve the effectiveness of treatments like endovascular coiling and flow diversion. The emphasis on partnerships and expansion into emerging intracranial aneurysm markets is also boosting their market influence.

Some prominent key players include:

Medtronic

Company Overview
Business Strategy
Key Product Offerings
Financial Performance
Key Performance Indicators
Risk Analysis
Recent Development
Regional Presence
SWOT Analysis

Stryker
MicroPort Scientific Corporation
Johnson & Johnson Services, Inc.
MicroVention Inc.
Integra LifeSciences
B. Braun Melsungen AG
Delta Surgical
Penumbra, Inc.

Browse Key Market Insights with Data Illustration:

Intracranial Aneurysm Market Size & Share, Growth Trends 2037

In the News

In May 2023, Stryker, one of the world's leading medical technology companies, announced that it completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage medical device company engaged in the design and development of neurointerventional devices for the treatment of intracranial aneurysms.
In April 2021, Medtronic plc a global leader in medical technology, received approval from the United States Food and Drug Administration (FDA) for its Pipeline Flex Embolization Device with Shield Technology. Medtronic developed Shield Technology, a proprietary breakthrough in biomaterial science, to advance flow diversion therapy by introducing the first surface-modified implant device with reduced material thrombogenicity, or the ability of the surface treatment material to form clots. NYU Langone Health in novel York City completed the nation's first patient procedure with the novel technology.

Frequently Asked Questions (FAQ)

The global intracranial aneurysm market registered a valuation of USD 1.37 billion in 2024 and is poised to expand at a CAGR of 9.0% during the forecast period, i.e., 2025-2037.

The global intracranial aneurysm sector registered a profitable valuation of USD 1.37 billion in 2024 and is poised to register USD 4.19 billion in 2037 expanding at a CAGR of 9.0% during the forecast period, i.e., 2025-2037.

The major players in the market are Medtronic plc, Stryker Corporation, MicroPort Scientific Corporation, Johnson & Johnson Services, Inc., MicroVention Inc., B. Braun Melsungen AG, Integra LifeSciences, and others.

By type, the endovascular coiling segment is poised to register the largest revenue share of 86.2% by 2037. The market growth is attributed to technological advancements, increased patient awareness, and the push for minimally invasive healthcare solutions.

North America is poised to register the largest revenue share of 29.7% by the end of 2037. The market growth can be attributed to a combination of technological advancements, increasing prevalence of risk factors, and robust healthcare infrastructure.

Intracranial Aneurysm Market - Top Companies and Manufacturers

Companies Dominating the Intracranial Aneurysm Market

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

How big is the intracranial aneurysm market?

What is the outlook for the intracranial aneurysm market?

Who are the major players dominating the intracranial aneurysm market?

Which type segment will capture the significant market share for the intracranial aneurysm sector by 2037?

Which region will provide more business opportunities for the growth of the intracranial aneurysm market in the future?